What does Nipro PharmaPackaging International do?

Nipro PharmaPackaging International is a wholesaler in Mechelen. Public Limited, started on 7 September 2015, 1 establishment.

What is the address of Nipro PharmaPackaging International?

The registered office of Nipro PharmaPackaging International is located at Blokhuisstraat 42, 2800 Mechelen.

Is Nipro PharmaPackaging International still active?

Yes. According to the CBE (30 October 2026) Nipro PharmaPackaging International is active, legal situation “Normale toestand”, started on 7 September 2015.

Is Nipro PharmaPackaging International registered on Peppol?

Yes, Nipro PharmaPackaging International is registered on the Peppol network with ID 0208:0636806780.

What is the enterprise number of Nipro PharmaPackaging International?

The enterprise number of Nipro PharmaPackaging International is BE0636806780.

When was Nipro PharmaPackaging International founded?

Nipro PharmaPackaging International was founded on 7 September 2015.

Who are the directors of Nipro PharmaPackaging International?

According to the 2025 annual accounts, the directors of Nipro PharmaPackaging International are: Stephan ARNOLD, Hideyuki NISHISAKO.

Is Nipro PharmaPackaging International a reliable company?

Databakkes does not pass judgement; this is what the sources say: Active according to the CBE since 7 September 2015; 5 annual accounts filed, latest fiscal year 2025; 2 directors known from the annual account.

How much profit did Nipro PharmaPackaging International make in 2025?

Nipro PharmaPackaging International recorded a loss after taxes of € 203,001 in financial year 2025.

What is the revenue of Nipro PharmaPackaging International?

In its most recent annual accounts (2025), Nipro PharmaPackaging International reported revenue of € 2,194,049.

How much does an employee at Nipro PharmaPackaging International earn?

The average wage cost per full-time employee at Nipro PharmaPackaging International was € 161,300 in 2025: staff costs of € 806,377 for 5 FTE, according to the annual account at the National Bank. That is the employer's cost, not net pay.

How many employees does Nipro PharmaPackaging International have?

According to the 2025 annual accounts, Nipro PharmaPackaging International has 5 full-time equivalents (FTE).

Nipro PharmaPackaging International (Public Limited)

Dossier Nipro PharmaPackaging International, printed on 30 October 2026 from databakkes.be/en/0636806780/nipro-pharmapackaging-international. Sources: CBE, National Bank of Belgium, Belgian Official Gazette.

Warning lights

Signals from the annual accounts, the CBE and the Official Gazette, each with its threshold and source. No score, no verdict.

Two loss years in a row NBB

Negative result in 2024 and 2025.

Financials

Financial year 2025

Nipro PharmaPackaging International from Mechelen, company number BE0636806780, closed financial year 2025 with a result of € -203,001 after tax. For that financial year Nipro PharmaPackaging International recorded revenue of € 2.2 million and equity of € 191.2 million. Compared with financial year 2024, the result moved from € -483,687 to € -203,001. The company made a loss. The company holds a healthy buffer. A strong own buffer against the debts. The most recent annual accounts were filed with the National Bank of Belgium on June 15, 2026.

What it is worth Healthy

€ 191.2 million

Assets minus debts, by the books. What is left if everything were sold and paid today.

Loss Caution

€ -203,001

▲ 58 % less loss than in 2024

Profit after tax over the fiscal year.

Cash in the bank

€ 105

▲ 12% vs 2024

Cash and bank balances on the last day of the fiscal year.

Where the profit goes Caution

Loss, nothing to pay out

Reserves fell to € 2.7 million.

People and assets in 2025

Full-time equivalents

Average over the fiscal year, from the social balance sheet.

Wage cost Staff costs are payroll only. Director pay sits with services and miscellaneous goods: € 15.5 million in 2025, together with rent, insurance, accountants and other services. The accounts do not split that further.

€ 806,377

▲ 1% vs 2024

€ 161,300 per full-time equivalent. Payroll staff only. What the director pays themselves is already netted into the gross margin and is not shown separately in the accounts.

Vehicles and equipment

€ 4,987

Book value of vehicles, furniture and equipment.

Debts at end 2025

Bank debt ≈ 8 years to go The accounts give the long-term loan and the part due within the year. The remainder divided by that part is the number of years at an equal pace; a new loan or early repayment changes it.

€ 145.4 million

▲ 105% vs 2024

€ 17.1 million is repaid this year. At this pace the long-term loan is gone in ≈ 8 years.

Owed to suppliers

€ 2.9 million

▲ 11% vs 2024

Supplier invoices still open on the last day of the fiscal year. Pays suppliers within 68 days on average.

Taxes and wages

€ 254,321

▲ 3% vs 2024

Taxes, VAT and social contributions still to pay.

Key figures per fiscal year Download key figures (CSV)
	2022	2023	2024	2025	Change 2024 → 2025
Revenue	€ 1,994,612 Revenue 2022: € 1,994,612 First fiscal year in the series	€ 2,697,176 Revenue 2023: € 2,697,176 ▲ 35% vs 2022 (€ 1,994,612) Favourable step	€ 3,241,246 Revenue 2024: € 3,241,246 ▲ 20% vs 2023 (€ 2,697,176) Favourable step	€ 2,194,049 Revenue 2025: € 2,194,049 ▼ 32% vs 2024 (€ 3,241,246) Unfavourable step	▼ 32%
Profit after taxes	€ 137,072 Profit after taxes 2022: € 137,072 First fiscal year in the series	€ 586,555 Profit after taxes 2023: € 586,555 ▲ € 449,483 vs 2022 (€ 137,072) Favourable step	€ -483,687 Profit after taxes 2024: € -483,687 ▼ € 1.1 million vs 2023 (€ 586,555) Unfavourable step	€ -203,001 Profit after taxes 2025: € -203,001 ▲ € 280,686 vs 2024 (€ -483,687) Favourable step	▲ € 280,686
Equity	€ 178,817,834 Equity 2022: € 178,817,834 First fiscal year in the series	€ 191,904,389 Equity 2023: € 191,904,389 ▲ 7% vs 2022 (€ 178,817,834) Favourable step	€ 191,420,702 Equity 2024: € 191,420,702 Unchanged (€ 191,904,389) Unfavourable step	€ 191,217,702 Equity 2025: € 191,217,702 Unchanged (€ 191,420,702) Unfavourable step
Total debts	€ 69,191,410 Total debts 2022: € 69,191,410 First fiscal year in the series	€ 110,808,509 Total debts 2023: € 110,808,509 ▲ 60% vs 2022 (€ 69,191,410) Unfavourable step	€ 152,251,369 Total debts 2024: € 152,251,369 ▲ 37% vs 2023 (€ 110,808,509) Unfavourable step	€ 171,181,920 Total debts 2025: € 171,181,920 ▲ 12% vs 2024 (€ 152,251,369) Unfavourable step	▲ 12%
Cash	€ 53,699 Cash 2022: € 53,699 First fiscal year in the series	€ 6,569 Cash 2023: € 6,569 ▼ 88% vs 2022 (€ 53,699) Unfavourable step	€ 93 Cash 2024: € 93 ▼ 99% vs 2023 (€ 6,569) Unfavourable step	€ 105 Cash 2025: € 105 ▲ 12% vs 2024 (€ 93) Favourable step	▲ 12%
Retained profit	€ 2,840,221 Retained profit 2022: € 2,840,221 First fiscal year in the series	€ 3,426,776 Retained profit 2023: € 3,426,776 ▲ 21% vs 2022 (€ 2,840,221) Favourable step	€ 2,943,089 Retained profit 2024: € 2,943,089 ▼ 14% vs 2023 (€ 3,426,776) Unfavourable step	€ 2,740,089 Retained profit 2025: € 2,740,089 ▼ 7% vs 2024 (€ 2,943,089) Unfavourable step	▼ 7%
Bank debt	€ 8,500,000 Bank debt 2022: € 8,500,000 First fiscal year in the series	€ 50,488,000 Bank debt 2023: € 50,488,000 ▲ € 42 million vs 2022 (€ 8,500,000) Unfavourable step	€ 70,920,364 Bank debt 2024: € 70,920,364 ▲ 40% vs 2023 (€ 50,488,000) Unfavourable step	€ 145,399,532 Bank debt 2025: € 145,399,532 ▲ 105% vs 2024 (€ 70,920,364) Unfavourable step	▲ 105%
Balance sheet total	€ 248,333,187 Balance sheet total 2022: € 248,333,187 First fiscal year in the series	€ 302,726,888 Balance sheet total 2023: € 302,726,888 ▲ 22% vs 2022 (€ 248,333,187) Unchanged	€ 343,693,155 Balance sheet total 2024: € 343,693,155 ▲ 14% vs 2023 (€ 302,726,888) Unchanged	€ 362,427,406 Balance sheet total 2025: € 362,427,406 ▲ 5% vs 2024 (€ 343,693,155) Unchanged	▲ 5%
Employees (FTE)	8 Employees (FTE) 2022: 8 First fiscal year in the series	6.7 Employees (FTE) 2023: 6.7 ▼ 1.3 vs 2022 (8) Unchanged	5 Employees (FTE) 2024: 5 ▼ 1.7 vs 2023 (6.7) Unchanged	5 Employees (FTE) 2025: 5 Unchanged (5) Unchanged

Key figures of Nipro PharmaPackaging International, fiscal years 2022 to 2025, from the annual accounts filed with the National Bank of Belgium.Next annual account (fiscal year 2026) expected before 31 July 2027.

What happened to Nipro PharmaPackaging International?

What happened at Nipro PharmaPackaging International in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:

2031 Stephan ARNOLD stepped down as director. NBB
2030 Hideyuki NISHISAKO stepped down as director. NBB
Jun 15, 2026 New annual accounts for financial year 2025: loss of € 203,001. Source: NBB ↗
2025 Stephan ARNOLD became a director. NBB
2024 Hideyuki NISHISAKO became a director. NBB
Jan 1, 2016 New establishment in Mechelen. KBO
Sep 7, 2015 Start of the company according to the CBE. KBO

In short

From € 137,072 profit in 2022 to € 203,001 loss in 2025.

Paid € 186,677 in corporate taxes since 2022.

Best year ever: 2023, with € 586,555 profit.

Pays suppliers within 68 days on average.

Original PDFs at the National Bank ↗

Management

NIPRO EUROPE GROUP COMPANIES 100%

Nipro PharmaPackaging International

Nipro PharmaPackaging Germany GmbH 100%

Nipro PharmaPackaging France 100%

Nipro PharmaPackaging Croatia LLC 100%

The shares are held by NIPRO EUROPE GROUP COMPANIES (100%). It owns 100% of Nipro PharmaPackaging Germany GmbH , 100% of Nipro PharmaPackaging France and 100% of Nipro PharmaPackaging Croatia LLC itself.

Directors

According to the 2025 annual accounts

Stephan ARNOLD

Managing director

since 2025 · until 2031

Hideyuki NISHISAKO

Director

since 2024 · until 2030

Shareholders

NIPRO EUROPE GROUP COMPANIES

100%

Participations

Nipro PharmaPackaging Germany GmbH

100%

Nipro PharmaPackaging France

100%

Nipro PharmaPackaging Croatia LLC

100%

Establishments

Establishment units

Physical locations of this company

Registered office

Blokhuisstraat 42

2800 Mechelen

Who else lives here?

A building full of entrepreneurs or one very busy letterbox? Another 4 companies are registered at this address.

All companies at this address →

NIPRO MEDICAL EUROPE

€ 385.9 million revenue · 2025

NIPRO EUROPE GROUP COMPANIES same network

€ 27.5 million revenue · 2025

NIPRO EUROPE HOLDING

UNIVERSAL RENAL CARE

€ 18,398 revenue · 2025

What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.

Details

Company number

0636.806.780

VAT number

BE 0636.806.780

Registered office

Blokhuisstraat 42, 2800 Mechelen

Names & denominations

Nipro PharmaPackaging International

Enterprise type

Rechtspersoon

Legal form

Public limited company

Legal situation

Normale toestand

Start date

7 September 2015

Peppol

Active · Active since 11 Dec 2025

Activities · NACE

Groothandel in farmaceutische en medische artikelen

Groothandel in porselein en glaswerk

Groothandel in kantoor- en schoolbenodigdheden

Niet-gespecialiseerde groothandel

Groothandel in parfumerieën en cosmetica

View on CBE Public ↗ Annual accounts (NBB) ↗

Nipro PharmaPackaging International

Warning lights

Financials

What happened to Nipro PharmaPackaging International?

Management

Directors

Shareholders

Participations

Establishments

Establishment units

Who else lives here?

Details

Frequently asked questions